ClearPoint Neuro, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Notes Payable (Details Narrative)

Notes Payable (Details Narrative) - USD ($)		1 Months Ended				3 Months Ended		9 Months Ended
Notes Payable (Details Narrative) - USD ($)	Apr. 04, 2016	Sep. 30, 2016	Dec. 31, 2015	Dec. 31, 2014	Mar. 31, 2014	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Debt Instrument [Line Items]
Proceeds from common stock called		$ 3,800,000	$ 4,700,000	$ 9,400,000	$ 3,500,000
Unamortized discount		$ 2,519,341				$ 2,519,341		$ 2,519,341
Other offering expenses			$ 166,080
Common stock par value (in dollars per share)		$ 0.01	$ 0.01			$ 0.01		$ 0.01
Loss on restructuring of debt						$ (933,134)		$ (811,909)
Private Placement (Securities Purchase Agreements) [Member] \| 12% Junior Secured Notes Payable 2014 [Member] \| Warrant [Member]
Debt Instrument [Line Items]
Number of each common stock called					0.01
Number of common stock called					27,937
Proceeds from common stock called					$ 3,725,000
Warrant exercise price (in dollars per share)					$ 70.00
Fair value					$ 413,057
Brainlab Senior Secured Note Payable [Member]
Debt Instrument [Line Items]
Stated interest rate			5.50%
Description of maturity date								Matures on December 31, 2018.
Debt face amount			$ 5,000,000
Description of payment terms								Principal and accrued interest is payable in a single aggregate installment upon maturity.
Brainlab Senior Secured Note Payable [Member] \| 2016 Securities Purchase Agreement (Patent And Technology License Agreement) [Member]
Debt Instrument [Line Items]
Debt cancelled principal amount	$ 1,000,000
Brainlab Senior Secured Note Payable [Member] \| 2016 Securities Purchase Agreement (Patent And Technology License Agreement) [Member] \| Common Stock [Member]
Debt Instrument [Line Items]
Common stock par value (in dollars per share)	$ 0.01
Number of common shares issued	1
Brainlab Senior Secured Note Payable [Member] \| 2016 Securities Purchase Agreement (Patent And Technology License Agreement) [Member] \| 2016 Series A Warrants [Member]
Debt Instrument [Line Items]
Number of each common stock called	0.40
Warrant exercise price (in dollars per share)	$ 16.23
Number of common shares issued	1
Brainlab Senior Secured Note Payable [Member] \| 2016 Securities Purchase Agreement (Patent And Technology License Agreement) [Member] \| 2016 Series B Warrants [Member]
Debt Instrument [Line Items]
Number of each common stock called	0.30
Warrant exercise price (in dollars per share)	$ 21.10
Number of common shares issued	1
Brainlab Senior Secured Note Payable [Member] \| 2016 Securities Purchase Agreement [Member]
Debt Instrument [Line Items]
Accrued interest	$ 740,000
Debt cancelled principal amount	$ 1,300,000
Number of units issued	99,310
Brainlab Senior Secured Note Payable [Member] \| 2016 Registration Rights Agreement [Member]
Debt Instrument [Line Items]
Debt face amount	$ 1,300,000
Brainlab Senior Secured Note Payable [Member] \| 2016 Registration Rights Agreement [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Stated interest rate	10.00%
Brainlab Senior Secured Note Payable [Member] \| 2016 Registration Rights Agreement [Member] \| Minimum [Member]
Debt Instrument [Line Items]
Stated interest rate	2.00%
Brainlab Senior Secured Note Payable [Member] \| Private Placement (Securities Purchase Agreements) [Member]
Debt Instrument [Line Items]
Debt face amount			740,000
Gain on foregoing of debt		$ 941,000				941,000		$ 941,000
2014 Secured Notes [Member] \| Private Placement (Securities Purchase Agreements) [Member]
Debt Instrument [Line Items]
Debt face amount					$ 3,725,000
Maturity period					5 years
Debt frequency of periodic payment					Semi-annually
Description of collateral terms					The 2014 Secured Notes are collateralized by a security interest in the Company’s property and assets, which security interest is junior and subordinate to the security interest that collateralizes the New Brainlab note.
Unamortized discount		145,271	301,531		$ 413,057	145,271		145,271
2014 Secured Notes [Member] \| Private Placement (Securities Purchase Agreements) [Member] \| Non-Employee Directors [Member]
Debt Instrument [Line Items]
Debt face amount					1,100,000
Fair value					30,210
Placement agents cash commission					$ 145,500
Number of warrants issued to placement agent					1,818
Other offering expenses		$ 65,321	$ 166,080		$ 76,186	$ 65,321		65,321
New Brainlab Note (amended and restated secured note) [Member] \| 2016 Securities Purchase Agreement [Member]
Debt Instrument [Line Items]
Debt face amount	$ 2,000,000
Maturity date	Dec. 31, 2018
Loss on restructuring of debt								$ 820,000